You can buy or sell PTI and other stocks, options, ETFs, and crypto commission-free!
Proteostasis Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF) and other diseases caused by an imbalance in the proteostasis network. Read More The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA. The listed name for PTI is Proteostasis Therapeutics, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Nov 5, After Hours